By Angelo DePalma, Ph.D. | The Defender | October 27, 2023 Pfizer-BioNTech delayed reporting vaccine-associated deaths among BNT162b2 clinical trial participants until after the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the product. The vaccine makers also failed to account for a large number of subjects who dropped out of the […]
How Pfizer Hid Nearly 80% of COVID Vaccine Trial Deaths From Regulators